theMednetRegister

Psychiatry   

Questions discussed in this category

What is your approach for managing persistent psychotic symptoms of a hallucinogen-induced persisting psychotic disorder (for example, related to SUD involving psilocybin or synthetic THC)?
In particular, how do you address primarily positive symptoms of somatic delusions, auditory hallucinations, and paranoid ideation in patients? How do...
1 Answer available
What would be your approach to managing social anxiety in teenage patients with ADHD, doing well in regards to academic functioning with their stimulant medications?
Please share options of treatment without discontinuing the stimulant as that include discontinuing the stimulant and using alternatives. 
1 Answer available
In what cases do you use baclofen for alcohol use disorder?
2 Answers available
Would you be comfortable using isotretinoin in a female teenage patient who has a history of depression that is now stable but with a prior suicide attempt two years ago?
7 Answers available
How do you approach the use of benzodiazepines in patients with chronic medical illnesses that may be susceptible to respiratory compromise (e.g., CHF, COPD, ILD)?
Should you work to wean patients of benzodiazepines? Is your approach different for patients who have been on benzodiazepines for years? What would yo...
3 Answers available
How do you differentiate between hyperactive delirium and excited catatonia?
1 Answer available
Do you observe worsening irritability, mood symptoms, or increased rates of suicidal ideation in patients with Bipolar Disorder who are using hormone birth control (hormone releasing IUD included)?
How do you address exacerbation of mood symptoms in patients who want to continue hormone birth control?
2 Answers available
When do you recommend acamprosate vs. naltrexone for medication-assisted therapy in alcohol use disorder?
9 Answers available
Are the laws regarding prescribing C-2 medications different for mail order pharmacies?
How is it that I'm able to prescribe medications to patients (in my state) via legitimate mail order pharmacies that are located in a different state?...
2 Answers available
What is your approach in counseling a patient with delusions of parasitosis?
4 Answers available
In a woman with bipolar disorder with a menstrual component would lamotrigine itself worsen the condition given that it interacts with prescribed estrogen?
Does lamotrigine interfere with baseline estradiol levels in a woman who is not prescribed estrogen otherwise?
1 Answer available
Do you use any alternative or non-FDA-approved treatments for smoking cessation?
Are any effective options available beyond nicotine replacement therapy, varenicline, or bupropion?
1 Answer available
What is the best approach to treatment for cenestopathies (sensation of electric current in patient's brain) accompanied by anxiety and inability to sleep?
4 Answers available
How do you approach a treatment relationship with a patient who is non-adherent to recommendations and also is not interested in transfer to another practitioner?
8 Answers available
How do you approach anxiety management for patients who have been on long-term (years or more) daily benzodiazepines?
How do you approach this in patients who are approaching or are over 65 given the contraindications of benzodiazepine use in geriatric populations? Wh...
7 Answers available
Have you observed adverse mental health side effects in patients who start montelukast?
In light of the FDA warning about mental health side effects of the medication have you observed in particular any patients develop suicidal thoughts ...
1 Answer available
What pharmacological management do you consider for self-injurious behavior in patients with autism spectrum disorder?
8 Answers available
What do you consider when selecting an antipsychotic medication for acute agitation?
Many institutions have been using droperidol in place of haloperidol due to drug shortages.
1 Answer available
What pharmacologic therapy, if any, do you recommend for treatment of borderline personality disorder?
2 Answers available
What are the most effective strategies for managing weight gain associated with antipsychotic medications?
11 Answers available
What recommendations do you have regarding the use of dronabinol to prevent cannabis withdrawal in an inpatient medical or psychiatric setting?
1 Answer available
How do you treat patients with comorbid Bipolar Disorder and ADHD?
When using a stimulant, how aggressive are you with an anti-manic mood stabilizer? 
4 Answers available
Do you screen for MTHFR polymorphisms in your patients with treatment-resistant depression?
1 Answer available
How do you approach treatment of depression in Graves' Disease?
1 Answer available
When do you use SNRIs or norepinephrine reuptake inhibitors (e.g., atomoxetine) for the treatment of ADHD?
5 Answers available
How do you treat withdrawal symptoms from kratom addiction?
1 Answer available
How do you manage antipsychotic-induced prolactinemia?
1 Answer available
What considerations do you take in starting stimulant medications for the management of adult ADHD?
Do you defer or avoid use in patients with untreated simple hypertension or other cardiac history?
4 Answers available
How do you address akathisia for patients who have had otherwise an excellent response to their antipsychotic treatment?
5 Answers available
What parameters do you follow to avoid rebound effects when using clonidine only for nightly or daily as-needed indications?
1 Answer available
What do you use for treatment-refractory anxiety where trials of antidepressants have not worked either from ability to tolerate or inadequate effect?
1 Answer available
How will you use xanomeline-trospium (KarXT, Cobenfy) for patients with schizophrenia?
2 Answers available
How do you treat depression symptoms in patients with Parkinson's disease?
2 Answers available
What is your approach to addressing dementia-related agitation for patients living at home with family?
1 Answer available
How do you manage clozapine related sedation for patients who have treatment resistant Schizophrenia and otherwise had good response to clozapine?
1 Answer available
How do you approach the use of SSRIs to treat bipolar depression?
How do you balance the benefits of treating depression versus the risk of transition to mania? Do you consider stopping the medication as soon as the ...
10 Answers available
How do you counsel patients regarding using stimulants for attention-deficit/hyperactivity disorder during pregnancy?
1 Answer available
What medications best treat Intermittent Explosive Disorder?
What medications bests treat Intermittent Explosive Disorder?
9 Answers available
How reliable do you find it to make the diagnosis of bipolar disorder based on a patient report of prior symptoms or questionnaire and not the actual observation of hypo/mania on the exam?
What are some ways to predict patient report alone may lead to a "false positive" bipolar disorder diagnosis and other psychiatric syndromes are prese...
2 Answers available
How do you approach stimulant-related insomnia for pediatric patients who are otherwise good responses to low-dose stimulant treatment for ADHD?
10 Answers available
What pharmacological management to you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?
What medications do you use in patients who already have existing obesity and metabolic syndrome?
3 Answers available
When do you consider using multiple antipsychotic medications for chronic management of psychosis?
Does your approach change when using a long-acting injection antipsychotic with oral antipsychotic medication?
2 Answers available
How do you manage withdrawal symptoms of SNRIs that exist even after slow taper?
1 Answer available
How do you approach a patient who exhibits classic bipolar symptomatology (including cycling sleep changes, behavioral changes, and mood changes) but has never responded to any form of adequate trials of mood stabilizer treatment?
When would you consider symptoms to be potentially of other etiology? Would you ever consider a conversion or functional diagnosis?
1 Answer available
What medications are preferred and contraindicated for insomnia in patients with a recent stroke or traumatic brain injury?
1 Answer available
When do you choose to switch to antidepressants vs augmentation in treatment-resistant depression?
4 Answers available
How do you treat extrapyramidal symptoms secondary to anti-psychotic use in patients who have not benefited from cogentin or benadryl?
1 Answer available
How do you manage emotional blunting due to SSRIs/SNRIs?
7 Answers available
How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?
1 Answer available
What medications have you had success with for patients with high functioning ASD and co-morbid ADHD and anxiety?
1 Answer available
Given some of the theoretical relationship between glutamate and OCD, do you ever consider the use of NMDA (or AMPA) antagonists for the treatment of refractory OCD?
1 Answer available
What is the best treatment for treatment resistant restless leg syndrome?
2 Answers available
How do you approach treatment-refractory schizophrenia which has not responded to multiple antipsychotic trials including clozapine?
11 Answers available
How do you counsel patients with bipolar disorder who want to breastfeed?
3 Answers available
What is your approach to assessing traumatic exposure in children?
2 Answers available
How do you engage and approach a patient presenting with psychotic symptoms who has demonstrated a pattern of malingering and also has polysubstance use disorder?
1 Answer available
How do you approach managing clozapine in patients who are critically ill?
1 Answer available
How do you address mental health and online presence with teenage patients?
2 Answers available
Would you use bupropion for mood disorder or substance use in an adult patient with previous childhood seizures that resolved?
1 Answer available
How do you approach antidepressant choices for patients with generalized anxiety disorder when the patient reports excessive sedation on low doses of SSRIs?
4 Answers available
What medications are safe to use to treat major depression and/or anxiety in a patient with closed-angle glaucoma?
In light of research that suggests SSRIs increase the risk of closed-angle glaucoma, Chen et al., PMID 28257449.
1 Answer available
Are there any potentially successful pharmacologic interventions (instead of CBT or behavioral interventions alone) for Schizoid personality disorder?
4 Answers available
Without any symptoms of drug-induced hyperprolactinemia, do you still consider changing atypical antipsychotics (that are working very well) if the prolactin levels are high in children undergoing puberty?
Is there a prolactin level in asymptomatic children when you should consider switching to alternative atypical antipsychotics?
2 Answers available
Would you consider over-the-counter dextromethorphan (low dose, slow titration) as augmentation in MDD?
Considering a growing interest in the use of dextromethorphan for depression (Majeed et al., PMID 33682569).
2 Answers available
What approach to antipsychotics do you take with patients with primary thought disorder (i.e. schizophrenia) who are now geriatric?
What would be the best treatment options to minimize long term impacts related to cognition?
1 Answer available
How do you cross-taper when switching from an SSRI to an SNRI?
1 Answer available
How do you counsel patients and caregivers on dietary interventions for autism?
Marí-Bauset et al., JCN 2014
1 Answer available
What or where is the best reference guide for managing patients with bipolar disorder who are on meds and want to become pregnant?
Can you include both patient directed and clinician directed resources?
1 Answer available
When do you use seizure prophylaxis in patients on clozapine?
6 Answers available
How do you treat a patient with moderate dementia who experiences a recurrence of depression?
3 Answers available
Do you warn patients about suicidal ideation when starting anti-seizure medications?
1 Answer available
What antidepressants are recommended for management of depression or anxiety in patients with spinal cord injuries?
Do you avoid certain antidepressants related to the risks on suppressing respiratory-drive which is potentially concerning in patients with high cord ...
1 Answer available
How do you treat a patient with shared delusional disorder aka folie à deux?
1 Answer available
When do you select cholinesterase inhibitors vs NMDA-antagonist medications in patients with moderate Alzheimer’s dementia?
1 Answer available
What is your approach to using ketamine for agitation in the ED setting?
1 Answer available
How do you manage obsessive-compulsive disorder refractory to high-dose SSRI and cognitive behavioral therapy?
1 Answer available
How do you approach switching from methadone to buprenorphine/naloxone for patients who want to change medication management for opioid use disorder?
3 Answers available
Do you believe that buspirone is ineffective in patients who are previously treated with benzodiazepines?
6 Answers available
How do you manage tacrolimus-related psychosis?
2 Answers available
What unique factors do you take into consideration for geriatric patients with a first lifetime episode depression?
1 Answer available
When do you consider using stimulants in patients with cognitive impairments secondary to traumatic brain injury?
1 Answer available
What is your approach to helping parents manage sleep disturbances in patients with autism spectrum disorder?
1 Answer available
What medications do you prioritize or avoid in Parkinson’s Disease-related psychosis and behavioral disturbance?
2 Answers available
How do you counsel elderly patients who demonstrate mild cognitive impairment but do not meet the criteria for a neurocognitive disorder?
1 Answer available
How do you navigate C-2 refills in patients who are stable in their treatment and do not otherwise need to be clinically seen monthly?
Would you consider charging a small fee for managing C-2 prescriptions between appointments instead of requiring the patient to come monthly?
4 Answers available
How do you implement antipsychotics in the management of agitation in Alzheimer’s patients?
1 Answer available
How do you titrate lithium for patients with bipolar affective disorder during pregnancy and immediately after delivery in the context of fluid shifts and changing levels?
2 Answers available
How do you address/manage the recreational use of dextromethorphan (sometimes called "robo-tripping") that has risen to the level of use disorder? 
What DSM-5 diagnosis and or diagnostic code do you use when treating this substance use disorder?
1 Answer available
Do you find that hydroxyzine worsens cognitive symptoms in patients who are already susceptible to cognitive impairment (i.e., schizophrenia, ADHD, dementia)?
2 Answers available
What is the best way to manage low systolic blood pressures on clozapine when the patient has failed multiple other antipsychotic trials?
1 Answer available
What do you do for patients who have received accidental extra dosages of long-acting injectable antipsychotics?
3 Answers available
How do you counsel patients when they ask whether the SSRI or SNRI antidepressant you have recommended will result in weight gain?
Have you found significant differences among SSRIs and SNRIs (e.g., paroxetine vs fluoxetine vs sertraline vs escitalopram vs duloxetine)? What data d...
3 Answers available
What do you do when a patient experiences multiple rounds of antidepressant-related tachyphylaxis?
1 Answer available
What precautions should be taken when discharging a patient from the medical setting on new medication assisted therapy for alcohol use disorder?
This is based on the recent publication by Bernstein et al., PMID 38551564 which investigated the increased rate of initiation of MAUD in the hospital...
4 Answers available
Do you ever use amantadine or modafinil to aid in the rehabilitation of patients with ischemic strokes?
In patients who have decreased arousal after ischemic stroke, do you use amantadine or modafinil to aid with wakefulness and interaction with therapy ...
1 Answer available
What is the best treatment option for a patient with bipolar disorder, who stopped her medication at the start of pregnancy and is now at the end of 2nd trimester?
4 Answers available
What is your approach to using stimulants in treating children with both ADHD and autism?
1 Answer available
How do you treat postpartum obsessive-compulsive disorder?
1 Answer available
When and how do you taper antipsychotics after a resolved episode of bipolar mania with psychotic features?
3 Answers available
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
1 Answer available
When do you consider lamotrigine in bipolar depression?
6 Answers available
How do you approach neuromodulation in postpartum depression?
How have you accessed neurosteroids (allopregnanolone) for patients?
1 Answer available
How do you differentiate demoralization from depression during cancer treatment?
2 Answers available
How do you approach the use of stimulants in patients with ADHD with previous or current substance use disorders?
2 Answers available
How do you manage nicotine withdrawal and smoking cessation in teens?
2 Answers available
Do you routinely prescribe an anticholinergic agent for EPS prophylaxis when starting or continuing antipsychotics or do you prefer to use it only as needed (prn) if/when symptoms develop?
3 Answers available
Do you avoid triptans in patients on SSRI's due to the potential risk of serotonin syndrome?
7 Answers available
When do you consider the use of clonidine in gabaergic withdrawal and how do you approach the risk of masking the autonomic signs of withdrawal when it is used?
Would you consider the risk of masking autonomic signs of alcohol withdrawal with clonidine different from beta-blockers?
1 Answer available
How do you approach patient requests for medical time away from work or other accommodations (such as disability paperwork) when the patients have mild-moderate symptoms being managed in the outpatient setting?
How do you evaluate for time off? Return to work? How do you deal with time off requests in the presence of non-adherence to treatment recommendations...
2 Answers available
Do you modify dosing or use of bupropion to mitigate seizure risk in patients without eating disorder who are restricting calories to lose weight?
Do you worry about additional increased risk of seizure for patients using medications to assist in weight loss such as GLP-1 agonists?
1 Answer available
Is there evidence to suggest there is a withdrawal syndrome from muscle relaxants such as tizanidine?
I have observed a trend where patients who are being tapered off of long-term benzodiazepine (especially in the geriatric population) prescriptions ar...
1 Answer available
What varying approaches do you take in suicide risk assessments?
Do you use different approaches in different settings (i.e., the ED vs. outpatient clinic)? Do you use different approaches for chronic vs acute suici...
3 Answers available
How do you advise families about the risks and benefits of long-term SSRI use for children who being treated at a very early age (e.g., early elementary school)?
Have any long-term studies been conducted to collect data on adults who were prescribed SSRIs throughout their childhood?
1 Answer available
How do you differentiate postpartum psychosis from postpartum obsessive compulsive disorder?
1 Answer available
How do you approach cognitive impairment in the assessment of transplant candidacy?
1 Answer available
How do you counsel patients on vaping cessation as compared to smoking cessation?
Is there evidence for the use of varenicline, bupropion, or other medication therapies to assist in tobacco vaping cessation?
1 Answer available
How do you approach the use of buprenorphine/naloxone in pregnant and breastfeeding patients?
In light of Straub et al's comparative study of combination vs buprenorphine alone
1 Answer available
How do you approach managing depression symptoms in patients who have had repeated high risk of bleeding?
When do you determine SSRI therapy is unsafe to pursue in such situations?
2 Answers available
When do you decide to use liothyronine (T3) for augmentation in treatment for treatment-resistant depression and how do you implement it?
1 Answer available
In what cases do you recommend the use of gabapentin for off-label use in alcohol use disorder?
3 Answers available
How do you approach managing perioperative anxiety in Mohs patients?
1 Answer available
What policies do you take regarding legalized recreational marijuana or medical marijuana use in transplant patients?
1 Answer available
What steps do you take in managing catatonia with limited response to lorazepam?
1 Answer available
How do you approach pain management needs for patients well-established on buprenorphine/naloxone?
1 Answer available
How do you approach the psychiatric symptom management of Huntington’s Disease?
1 Answer available
How do you manage stroke-related abulia?
1 Answer available
How do you differentiate Down syndrome disintegrative disorder from Alzheimer’s disease?
1 Answer available
What is your approach to managing a patient with egodystonic pedophilia thoughts?
1 Answer available
Do you prescribe linezolid to patients who are concomitantly on an SSRI?
7 Answers available
Do you avoid SSRIs in patients with a history of RCVS?
2 Answers available
Would you avoid the use of keppra in patients with TBI due to concerns for worsening agitation?
2 Answers available
How will your approach to screening and diagnosis of early dementia change given newly available therapies for early Alzheimer's disease?
5 Answers available
What are the recommendations for considering deep brain stimulation in a patient with tremors and dementia or mild cognitive impairment?
Does the approach differ if the tremor stems from essential tremor or Parkinson's disease?
1 Answer available
In what clinical situation would you consider using benzodiazepines in patients with dementia?
2 Answers available
How do you approach treating patients with delusions of parasitosis who can not tolerate an antipsychotic?
1 Answer available
How would you adjust the steroid dose for steroid-induced psychosis in a patient being treated for secondary HLH with the HLH-94 protocol?
1 Answer available
What work-up do you recommend in patients with early-onset dementia?
Which genetic/other testing should be considered in an early-onset dementia work-up? 
1 Answer available
How do you evaluate patients with suspected pseudo-dementia?
1 Answer available
Below what eGFR would you consider discontinuing lithium in a bipolar disorder patient with chronic kidney disease?
1 Answer available
Is it possible to develop worsening motor features of Parkinson's disease (PD) when using clozapine (for treatment of PD psychosis) above a certain dose?
If so, what is the recommended maximum dose of clozapine for PD patients? 
1 Answer available
How do you approach the management of patients on lamotrigine who develop a minor rash?
Should one restart lamotrigine or look for an alternative? If no other alternative available, is slow titration vs regular titration preferred?
4 Answers available
Is there a role for medications, beyond treatment for concomitant psychiatric disorders, in the management of pediatric amplified musculoskeletal pain syndrome?
1 Answer available
What is your approach to using apremilast for psoriatic arthritis in patients with history of depression?
1 Answer available
How would you manage a patient with secondary progressive multiple sclerosis manifesting with increased neuropsychiatric manifestations (ex. psychosis) with no recent changes on brain MRI?
1 Answer available
Are there certain sedatives or anti-epileptic meds to avoid in patients with IDD?
What are your thoughts on the ethics of inpatient use of sedatives in these patients to help with agitation to “protect themselves from harm and...
4 Answers available
How do you treat behavioral disturbances in patients with dementia with Lewy bodies?
How do you treat dangerous behavioral disturbances (aggression, nighttime wandering) in patients with dementia with Lewy bodies (DLB)?
1 Answer available
Do you use pimavanserin to treat psychotic symptoms in Lewy body dementia?
1 Answer available
How do you approach the workup and management of patients with suspected functional neurologic disorders?
What testing do you typically proceed with?
1 Answer available
How do you approach NSAID use in patients on SSRIs?
Do you avoid due to the increased risk of GI adverse events?
1 Answer available
Do you taper memantine after completion of 24 weeks of therapy?
There does not appear to be any guidance from the most recent published protocols on this topic. For individuals with dementia, recommendations call f...
3 Answers available
How do you manage patients with dementia who require but cannot tolerate an aquaplast mask for radiation therapy?
Benzodiazepines are not ideal in this population. Are there superior alternatives, perhaps antipsychotics, that are effective and superior?
1 Answer available
What is the best way to manage severe claustrophobia and anxiety for Thermoplastic masks?
4 Answers available


Papers discussed in this category

Paediatr Drugs, 2017 Aug
Fibromyalgia: Treating Pain in the Juvenile Patient.
Pain Med, 2017 05 01
Trends in Medicalization of Children with Amplified Musculoskeletal Pain Syndrome.
Journal of psychiatric practice, 2018-11
Association Between Delusions of Infestation and Prescribed Narcotic and Stimulant Use.
Journal of the American Academy of Dermatology, 2019-05
Diagnosis and management of delusional parasitosis.
Med Hypotheses, 2006 Nov 28
Delusional parasitosis and the dopamine transporter. A new insight of etiology?
J Am Acad Dermatol, 2021 Apr 18
Stimulant use in patients presenting with psychocutaneous disorders.
Prog Neuropsychopharmacol Biol Psychiatry,
Effects of pimozide on the psychopathology of delusional disorder.
Antimicrob Agents Chemother, 2008 Nov 17
A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection.
The New England journal of medicine, 2012-03-01
Placebo-controlled trial of amantadine for severe traumatic brain injury.
Neurocritical care, 2020 Aug
Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review.
Neurocritical care, 2021 Feb
Amantadine and Modafinil as Neurostimulants Following Acute Stroke: A Retrospective Study of Intensive Care Unit Patients.
Stroke, 2017 Apr 12
MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.
Mov Disord Clin Pract, 2022 Oct 23
Clozapine Is Severely Underused in Parkinson's Disease Patients.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 2022 Aug 15
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
The journal of prevention of Alzheimer's disease, 2022
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force.
JAMA network open, 2022 Dec 01
Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants.
International journal of antimicrobial agents, 2023 Jun 08
Dose optimisation of linezolid in critically ill patients based on a population pharmacokinetic model: A two-centre prospective interventional study.
Pharmacy (Basel, Switzerland), 2023 Nov 20
The Association of Serotonin Toxicity with Combination Linezolid-Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis.
International journal of antimicrobial agents, 2023 May 07
Real-world evaluation of linezolid-associated serotonin toxicity with and without concurrent serotonergic agents.
Headache, 2010-06
The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
Headache, 2012 Jan 30
Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome.
Neurology, 2019 Dec 02
Triptan and ergotamine overdoses in the United States: Analysis of the National Poison Data System.
Headache, 2023 Jan 27
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.
Cureus, 2023 May 11
Serotonin Syndrome: The Role of Pharmacology in Understanding Its Occurrence.
JAMA neurology, 2018-05-01
Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
Frontiers in human neuroscience, 2022 May 13
Cognitive Impact of Deep Brain Stimulation in Parkinson's Disease Patients: A Systematic Review.
Frontiers in human neuroscience, 2024 Feb 02
Cognitive outcomes in patients with essential tremor treated with deep brain stimulation: a systematic review.
The American journal of psychiatry, 2022 Aug
Dementia Is More Than Memory Loss: Neuropsychiatric Symptoms of Dementia and Their Nonpharmacological and Pharmacological Management.
Psychiatry research, 2020 Dec 13
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.
Journal of psychopharmacology (Oxford, England), 2018 Jan 17
Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.
Nature reviews. Disease primers, 2024 Jul 18
Catatonia.
Pharmacological research, 2016 Aug 10
Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies.
The Annals of pharmacotherapy, 2018 Aug 06
Clinical Management of Bleeding Risk With Antidepressants.
Addiction (Abingdon, England), 2024 May 22
Changes in self-reported cannabis use in the United States from 1979 to 2022.
Journal of the American Heart Association, 2024 Feb 28
Association of Cannabis Use With Cardiovascular Outcomes Among US Adults.
Frontiers in pharmacology, 2024 May 22
Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and .
J Acad Consult Liaison Psychiatry, 2023 Nov-Dec
Delayed-Onset Psychosis Secondary to Tacrolimus Neurotoxicity After Lung Transplant: A Case Report and Systematic Review.
Case reports in nephrology and dialysis, 2021 Aug 04
When Paranoia Comes with the Treatment: Psychosis Associated with Tacrolimus Use.
The primary care companion for CNS disorders, 2022 Dec 08
Psychosis Associated With Tacrolimus at Therapeutic Serum Levels.
Transplantation direct, 2023 Jul 12
The Association of Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function.
The American journal of emergency medicine, 2017-07
Ketamine as a first-line treatment for severely agitated emergency department patients.
The Journal of emergency medicine, 2019 Nov 15
Evaluation of Ketamine for Excited Delirium Syndrome in the Adult Emergency Department.
Am J Emerg Med, 2020 Jul
Effectiveness and safety of droperidol in a United States emergency department.
The western journal of emergency medicine, 2012 Feb
The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.
Focus (American Psychiatric Publishing), 2023 Jan 16
Updates in the Assessment and Management of Agitation.
The western journal of emergency medicine, 2020 Jul 02
The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department.
Archives of sexual behavior, 1988-06
Beta-blocker effects on sexual function in normal males.
The mental health clinician, 2016 Jun 29
Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review.
Cortex; a journal devoted to the study of the nervous system and behavior, 2015 Aug 13
Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?
The Lancet. Neurology, 2013-07
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Journal of neurology, neurosurgery, and psychiatry, 2014 May 14
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
Journal of neurology, neurosurgery, and psychiatry, 2010 Apr 14
Factor analysis of behavioural symptoms in Huntington's disease.
The American journal of psychiatry, 2005 Apr
Critical periods of suicide risk in Huntington's disease.
JAMA internal medicine, 2019 Oct 01
Acute Pain Management in Patients Treated With Buprenorphine: A Teachable Moment.
Frontiers in psychiatry, 2018 Oct 08
Tailored-Dose Baclofen in the Management of Alcoholism: A Retrospective Study of 144 Outpatients Followed for 3 Years in a French General Practice.
Pharmacoepidemiology and drug safety, 2018 Sep 25
Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
The Journal of clinical psychiatry, 2020 Aug 04
Individualized, High-Dose Baclofen for Reduction in Alcohol Intake in Persons With High Levels of Consumption.
JAMA network open, 2024 Mar 04
Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia: A Systematic Review and Network Meta-Analysis.
The American journal of psychiatry, 2011-10
Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2021 Feb 09
Optimal Treatment of Depression and Anxiety in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society, 2021 Mar 12
Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment.
Neurology, 2022 Oct 11
Effects of Exercise on Depressive Symptoms in Patients With Parkinson Disease: A Meta-analysis.
Scientific reports, 2023 Nov 28
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity.
JCI insight, 2023 Jun 22
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission.
Biological psychiatry, 2010-01-15
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.
Molecular psychiatry, 2018-10-03
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Journal of affective disorders, 2020 Jul 21
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.
The Journal of clinical psychiatry, 2023 Feb 01
Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study.
CNS drugs, 2023 Aug 09
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023 May 12
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.
Alcohol (Fayetteville, N.Y.), 2014-06
The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome.
The mental health clinician, 2016 Jun 29
Management of antipsychotic-induced hyperprolactinemia.
Journal of the American College of Cardiology, 2020 Aug 18
Cardiovascular Effects of ADHD Therapies: JACC Review Topic of the Week.
Annals of internal medicine, 2024 Jul 02
Medication-Induced Weight Change Across Common Antidepressant Treatments : A Target Trial Emulation Study.
Oxford medical case reports, 2024 Feb 16
Maximal Tizanidine withdrawal managed with dexmedetomidine: a vital intervention.
Cureus, 2024 Feb 02
A Case of Tizanidine Withdrawal and Road to Recovery.
Cureus, 2023 Nov 22
A Case of Tizanidine Withdrawal Syndrome: Features and Management in the Emergency Department.
CNS drugs, 2024 Mar 19
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders.
Psychiatry research, 2024 Mar 20
Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.
Indian journal of psychological medicine, 2019 Mar-Apr
Use of Stimulants in Patients with Psychosis Having Past History of or Co-occurring Attention Deficit Hyperactivity Disorder: Is it Safe?
International journal of molecular sciences, 2022 Mar 04
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway.
Neurology, 1991 Mar
Clozapine-related seizures.
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2013 Aug 31
Use of anticonvulsants as prophylaxis for seizures in patients on clozapine.
JAMA psychiatry, 2023 Sep 01
Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.
Cureus, 2021 Jan 26
Considering Loxapine Instead of Clozapine: A Case Series and Literature Review.
Schizophrenia research, 2017-11
Ketogenic diet in the treatment of schizoaffective disorder: Two case studies.
Schizophrenia research, 2019-06
The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies.
Current opinion in endocrinology, diabetes, and obesity, 2020 Oct
Ketogenic diet as a metabolic treatment for mental illness.
Frontiers in psychiatry, 2022 Jul 06
The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients.
Clinical toxicology (Philadelphia, Pa.), 2008-09
Dextromethorphan-induced serotonin syndrome.
BMJ case reports, 2017-08-07
Serotonin syndrome caused by drug to drug interaction between escitalopram and dextromethorphan.
The primary care companion for CNS disorders, 2018 Dec 20
Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.
Therapeutic advances in psychopharmacology, 2022 May 24
Treatment strategies for clozapine-induced hypotension: a systematic review.
Actas espanolas de psiquiatria, 2016 May 01
Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).
Journal of clinical psychopharmacology, 1990-02
Is buspirone effective for panic disorder?
The American journal of drug and alcohol abuse, 2023 Mar 15
Successful treatment of dextromethorphan use disorder with combined naltrexone and gabapentin: a case report.
The American journal of psychiatry, 2012-12
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

Related Topics

Copyright © 2024 theMednet
All Rights Reserved.